MCID: VRL011
MIFTS: 63

Viral Infectious Disease

Categories: Infectious diseases, Respiratory diseases

Aliases & Classifications for Viral Infectious Disease

Summaries for Viral Infectious Disease

MedlinePlus : 43 Viruses are very tiny germs. They are made of genetic material inside of a protein coating. Viruses cause familiar infectious diseases such as the common cold, flu and warts. They also cause severe illnesses such as HIV/AIDS, smallpox, and Ebola. Viruses are like hijackers. They invade living, normal cells and use those cells to multiply and produce other viruses like themselves. This can kill, damage, or change the cells and make you sick. Different viruses attack certain cells in your body such as your liver, respiratory system, or blood. When you get a virus, you may not always get sick from it. Your immune system may be able to fight it off. For most viral infections, treatments can only help with symptoms while you wait for your immune system to fight off the virus. Antibiotics do not work for viral infections. There are antiviral medicines to treat some viral infections. Vaccines can help prevent you from getting many viral diseases.

MalaCards based summary : Viral Infectious Disease, also known as arbovirus infections, is related to chronic active epstein-barr virus infection and hepatitis c virus, and has symptoms including fever, pruritus and pathological conditions, signs and symptoms. An important gene associated with Viral Infectious Disease is TLR9 (Toll Like Receptor 9), and among its related pathways/superpathways are Innate Immune System and PEDF Induced Signaling. The drugs Zinc and Maraviroc have been mentioned in the context of this disorder. Affiliated tissues include liver, testes and t cells, and related phenotypes are cellular and hematopoietic system

Disease Ontology : 12 A disease by infectious agent that results in infection, has material basis in Viruses.

CDC : 3 Powassan (POW) virus is transmitted to humans by infected ticks. Approximately 100 cases of POW virus disease were reported in the United States over the past 10 years. Most cases have occurred in the Northeast and Great Lakes region. Signs and symptoms of infection can include fever, headache, vomiting, weakness, confusion, seizures, and memory loss. Long-term neurologic problems may occur. There is no specific treatment, but people with severe POW virus illnesses often need to be hospitalized to receive respiratory support, intravenous fluids, or medications to reduce swelling in the brain.

Wikipedia : 76 A viral disease (or viral infection) occurs when an organism\'s body is invaded by pathogenic viruses,... more...

Related Diseases for Viral Infectious Disease

Diseases related to Viral Infectious Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 293)
# Related Disease Score Top Affiliating Genes
1 chronic active epstein-barr virus infection 35.2 IFNG IL10 IL2
2 hepatitis c virus 33.9 CCR5 DDX58 IFIH1 IFNG IRF3 IRF7
3 tick-borne encephalitis 33.1 CCR5 CXCL10 IL10 TLR3
4 yellow fever 33.1 CCR5 IRF7 TLR9
5 la crosse encephalitis 33.0 CD40LG DDX58 IFNB1 IRF3
6 zika fever 33.0 CD40LG IFNB1
7 ross river fever 33.0 CD40LG IL10
8 poliomyelitis 33.0 IFNG IL10 TNF
9 progressive multifocal leukoencephalopathy 33.0 CD40LG IL2 TNF
10 hepatitis a 32.9 CD40LG IFNA2 TNF
11 hemorrhagic fever with renal syndrome 32.9 CD40LG IL10 TNF
12 marburg hemorrhagic fever 32.9 IFNB1 TNF
13 kyasanur forest disease 32.9 CD40LG IFNA1
14 smallpox 32.9 IFNG IL2 TNF
15 chikungunya 32.9 CD40LG DDX58 MAVS TNF
16 mumps 32.9 CD40LG IFNG IL2 TNF
17 tropical spastic paraparesis 32.9 IFNG IL10 IL2
18 rubella 32.9 CD40LG IL10 TNF
19 herpes zoster 32.8 IFNA2 IFNG IL10 IL2
20 hepatitis e 32.8 CD40LG DDX58 IFNG TLR3 TNF
21 newcastle disease 32.8 DDX58 IFNA1 IFNB1 IRF3 IRF7
22 japanese encephalitis 32.8 CXCL10 DDX58 IFNB1 TLR3 TNF
23 rabies 32.8 CD40LG CXCL10 IRF3 MX1 TLR3
24 vaccinia 32.7 IFNA1 IFNB1 IL2 IRF3 IRF7
25 hepatitis b 32.7 IFNA1 IFNA2 IFNG TNF
26 herpes simplex 32.5 DDX58 IFIH1 IFNA1 IFNB1 IRF3 TLR3
27 severe acute respiratory syndrome 32.4 CD40LG CXCL10 IFNA1 IFNB1 IFNG IRF3
28 measles 32.2 CD40LG DDX58 IFIH1 IFNA1 IFNB1 IFNG
29 human immunodeficiency virus infectious disease 32.0 CCR5 CD40LG IFNA1 IFNG IL10 IL2
30 hepatitis c 31.9 CXCL10 DDX58 IFNA1 IFNA2 IFNB1 IFNG
31 influenza 31.8 DDX58 IFIH1 IFNA1 IFNB1 IFNG IRF3
32 immunodeficiency, x-linked, with magnesium defect, epstein-barr virus infection, and neoplasia 12.5
33 zika virus infection 12.4
34 congenital herpes simplex virus infection 12.2
35 x-linked magnesium deficiency with epstein-barr virus infection and neoplasia 12.2
36 hendra virus infection 12.1
37 primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection 12.1
38 congenital epstein-barr virus infection 12.0
39 nipah virus disease 12.0
40 simian b virus infection 12.0
41 immunodeficiency 31b 11.8
42 caspase 8 deficiency 11.7
43 oral erosive lichen 11.3 IFNA1 IFNB1
44 plague 11.2 CCR5 DDX58 TLR9
45 septicemic plague 11.2 IFNB1 IRF3 TLR7
46 eczema herpeticum 11.2 IFNG IRF3 IRF7
47 oral tuberculosis 11.2 IL2 TNF
48 variola major 11.2 IFNG IL2 TLR3
49 punctate inner choroidopathy 11.2 IL10 TNF
50 central nervous system vasculitis 11.2 CD40LG TLR9 TNF

Graphical network of the top 20 diseases related to Viral Infectious Disease:



Diseases related to Viral Infectious Disease

Symptoms & Phenotypes for Viral Infectious Disease

UMLS symptoms related to Viral Infectious Disease:


fever, pruritus, pathological conditions, signs and symptoms

MGI Mouse Phenotypes related to Viral Infectious Disease:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 cellular MP:0005384 10.25 IFIH1 CCR5 CD40LG IFNG CXCL10 IL10
2 hematopoietic system MP:0005397 10.24 IL2 IFIH1 CCR5 IFNB1 IFNG CD40LG
3 homeostasis/metabolism MP:0005376 10.22 IL2 IFIH1 CCR5 IFNB1 IFNG CD40LG
4 immune system MP:0005387 10.16 IL2 IFIH1 CCR5 IFNB1 IFNG CD40LG
5 digestive/alimentary MP:0005381 10.01 DDX58 CCR5 IFNG IL10 IL2 TLR9
6 mortality/aging MP:0010768 9.8 DDX58 IFIH1 CCR5 CD40LG IFNG CXCL10
7 liver/biliary system MP:0005370 9.76 DDX58 IFIH1 CCR5 IFNG IL10 IL2
8 neoplasm MP:0002006 9.28 IL2 CCR5 IFNB1 IFNG IL10 DDX58

Drugs & Therapeutics for Viral Infectious Disease

Drugs for Viral Infectious Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 1205)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Zinc Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 7440-66-6 23994
2
Maraviroc Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 376348-65-1 3002977
3
Foscarnet Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 63585-09-1, 4428-95-9 3415
4
rituximab Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 174722-31-7 10201696
5
alemtuzumab Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 216503-57-0
6
Pioglitazone Approved, Investigational Phase 4,Phase 2,Not Applicable 111025-46-8 4829
7
Fludarabine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 21679-14-1, 75607-67-9 30751
8
Etoposide Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 33419-42-0 36462
9
Enfuvirtide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 159519-65-0 16130199
10
Doxorubicin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 23214-92-8 31703
11
Metformin Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 657-24-9 14219 4091
12
Abatacept Approved Phase 4,Phase 2,Not Applicable 332348-12-6 10237
13
Isoniazid Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 54-85-3 3767
14
Ciprofloxacin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 85721-33-1 2764
15
Ribavirin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 36791-04-5 37542
16
Ritonavir Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 155213-67-5 392622
17
chloroquine Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 54-05-7 2719
18
Ezetimibe Approved Phase 4,Phase 2,Phase 1 163222-33-1 150311
19
Lamivudine Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 134678-17-4 60825
20
Doxycycline Approved, Investigational, Vet_approved Phase 4,Phase 2,Not Applicable,Early Phase 1 564-25-0 54671203
21
Lopinavir Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 192725-17-0 92727
22
Rifampicin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 13292-46-1 5458213 5381226
23
Mannitol Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 69-65-8 453 6251
24
Albendazole Approved, Vet_approved Phase 4,Phase 3,Not Applicable 54965-21-8 2082
25
Dopamine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 51-61-6, 62-31-7 681
26
Ganciclovir Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 82410-32-0 3454
27
Darunavir Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 635728-49-3, 206361-99-1 213039
28
Azithromycin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 83905-01-5 55185 447043
29
Nevirapine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 129618-40-2 4463
30
Amphotericin B Approved, Investigational Phase 4,Phase 2 1397-89-3 14956 5280965
31
Ephedrine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 299-42-3 9294
32
Abacavir Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 136470-78-5 65140 441300
33
Vincristine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 2068-78-2, 57-22-7 5978
34
Pseudoephedrine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 90-82-4 7028
35
Methotrexate Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 1959-05-2, 59-05-2 126941
36
Ketotifen Approved Phase 4 34580-14-8, 34580-13-7 3827
37
Salicylic acid Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 69-72-7 338
38
Didanosine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 69655-05-6 50599
39
Thymalfasin Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2 62304-98-7
40
Aspirin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-78-2 2244
41
Heroin Approved, Illicit, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 561-27-3 5462328
42
Phenylephrine Approved Phase 4,Phase 3,Phase 2,Phase 1 59-42-7 6041
43
Cytarabine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable 147-94-4 6253
44
Telbivudine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 3424-98-4 159269
45
Zidovudine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 30516-87-1 35370
46
Basiliximab Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 152923-56-3, 179045-86-4
47
Methadone Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 76-99-3 4095
48
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 22916-47-8 4189
49
Oseltamivir Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 204255-11-8, 196618-13-0 65028
50
Formaldehyde Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 50-00-0 712

Interventional clinical trials:

(show top 50) (show all 10000)
# Name Status NCT ID Phase Drugs
1 Study of Immune Responses After Vaccination Against Seasonal Influenza Virus and Against Influenza H1N1-v Pandemic Virus in a Medical Staff. Unknown status NCT01063608 Phase 4
2 Treatment of Liver Cirrhosis Due to Hepatitis B Virus With Fuzheng Huayu and Entecavir Unknown status NCT02241590 Phase 4 Entecavir + Placebo;Entecavir + Fuzheng Huayu Tablet
3 Efficacy of Antiviral Therapy After Radical Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma Unknown status NCT00768157 Phase 4 antiviral treatment (lamivudine or entecavir)
4 Hepatitis C in Renal Transplant Recipients Unknown status NCT02108301 Phase 4 tacrolimus-cyclosporine A
5 Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using Transcatheter Arterial Chemoembolization (TACE) With Anti-hepatitis B Virus (Anti-HBV) Therapy Unknown status NCT01102335 Phase 4 Telbivudine
6 The Impact of Vitamin on the Clinical Course in Cases Infected by Novel H1N1 Influenza Virus A Unknown status NCT01127282 Phase 4 Vitamin (vitamin A 15 mg,C 500 mg, E 400IU);Placebo (digestive tablet)
7 Diagnosis and Treatment of Co-infection With Human Immunodeficiency Virus /Latent Tuberculosis Infection (HIV/TBL) Unknown status NCT01875952 Phase 4 Isoniazid
8 Efficacy of PTX+IFN Alpha+ RBV on Hepatitis C Virus Coinfected HIV Patients Unknown status NCT02008214 Phase 4 Pentoxifylline;Placebo
9 Topical Cyclosporine for the Treatment of Dry Eye in Patients Infected With the Human Immunodeficiency Virus Unknown status NCT00797030 Phase 4 cyclosporine and sodium carboximethycellulose;sodium carboximethycellulose
10 Peginterferon Alfa-2a, Ribavirin, Amantadine/Placebo in Hepatitis C Virus (HCV)-Genotype-1-Infection (PRAMA) Unknown status NCT00127777 Phase 4 Amantadine sulphate (in addition to standard treatment)
11 Entecavir for Chronic Hepatitis B Patients With Persistently Normal ALT Unknown status NCT01833611 Phase 4 Entecavir;placebo
12 Entecavir Plus Tenofovir Combination in Subjects With Multi-drug Resistant Chronic Hepatitis B Virus Infection Unknown status NCT01594905 Phase 4 Entecavir + Tenofovir (MDR group)
13 Hepatitis B Virus (HBV) Antibody (Anti-HBs) Booster Program for the Production of Hepatitis B Immune Globulin (HBIG) Unknown status NCT01311674 Phase 4
14 Study of Ezetimibe for Chronic Hepatitis C Virus (HCV) Infection in Liver Transplant Candidates (EZE-2) Unknown status NCT02768545 Phase 4 Ezetimibe
15 Antibody Response of a Boosted Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children Unknown status NCT01954810 Phase 4
16 Ciprofloxacin for Prevention of BK Infection Unknown status NCT01789203 Phase 4 Ciprofloxacin;placebo
17 Entecavir for Patients With Decompensated Hepatitis B Virus (HBV)-Related Cirrhosis Unknown status NCT00663182 Phase 4 Entecavir
18 Comparison of the Cellular and the Humoral Immunogenicity, Safety of Different Trivalent Influenza Vaccines Unknown status NCT01119157 Phase 4
19 A Pilot Study to Treat Patients With Chronic Hepatitis C Virus (HCV) Genotype 1 and End-Stage Renal Disease (ESRD) Unknown status NCT01731301 Phase 4 Ribavirin;Peginterferon;Boceprevir
20 Traditional Chinese Medicine Combined With Entecavir to Treat Refractory Liver Fibrosis in Liver Cirrhosis Due to HBV Unknown status NCT02241616 Phase 4 Entecavir+Fuzheng Huayu+TCM Granule
21 The Effect and Safety of the Seasonal Trivalent Influenza Vaccine in Chronic Kidney Disease Patients Not on Dialysis Unknown status NCT02105519 Phase 4
22 Does the HPV Vaccine Cause the Same Response in Adolescent Kidney and Liver Transplant Patients as in Healthy Controls? Unknown status NCT01101750 Phase 4
23 TO Compare the Triple Drug Therapy and Dual Therapy . Unknown status NCT02075242 Phase 4 Mycophenolate Mofetil;Tacrolimus
24 Hansenula-derived Pegylated Interferon in Treatment of Patients With Chronic Hepatitis C Unknown status NCT01649245 Phase 4 Reiferon retard
25 Improved Prevention of Perinatal Hepatitis B Transmission Unknown status NCT01133184 Phase 4
26 Phase IV Study to Evaluate the Efficacy/Safety to Extend Treatment and High Dose of Ribavirin in co-Infected Patients Unknown status NCT00526448 Phase 4 ribavirin;ribavirin;Peginterferon alfa-2a;epoetin beta
27 Effect of HIV and/or Active Tuberculosis on the Immune Responses to Trivalent Influenza Vaccine (TIV) in Adults Unknown status NCT01811823 Phase 4
28 Banlangen Granules Anti-seasonal Influenza Study Unknown status NCT02232945 Phase 4 placebo of oseltamivir phosphate;oseltamivir phosphate;Banlangen (Radix Isatidis) granules;placebo of Banlangen(Radix Isatidis) granules
29 Influence of Hepatic Steatosis on the Therapeutic Effect of Entecavir in Chronic Hepatitis B Patients Unknown status NCT01148576 Phase 4 entecavir;entecavir;essentiale + entecavir;Vitamin E + entecavir
30 Chinese Medicinal Herbs Treatment on Novel Influenza A (H1N1)Pneumonia: Multi-centre, Prospective, Randomized Controlled Study Unknown status NCT00936013 Phase 4 oseltamivir;oseltamivir and chinese medicinal herbs
31 Antiviral Therapy in Hepatitis B Virus (HBV)-Related Advanced Liver Disease Patients Unknown status NCT00823550 Phase 4 Entecavir;Lamivudine
32 High Intensity Focused Ultrasound Ablation Virus Myomectomy to Treat Uterine Fibroids Unknown status NCT01239641 Phase 4
33 Therapy With Ledipasvir/Sofosbuvir in Patients With Genotype 1 HCV Infection Receiving Opiate Substitution Therapy Unknown status NCT02638233 Phase 4 Sofosbuvir 400mg / Ledipasvir 90 mg (FDC)
34 Efficacy and Safety Study of Telbivudine to Prevent Perinatal Transmission Unknown status NCT00939068 Phase 4 Telbivudine
35 Study to Evaluate the Non-inferiority of Cavir in HBeAg(+)Chronic Hepatitis B Patients Treated With Baraclude Unknown status NCT02523547 Phase 4 Cavir;Baraclude
36 7-valent Pneumococcal Conjugated Vaccination Unknown status NCT00885625 Phase 4
37 Cellular Immunity in Adult Hepatitis B-vaccinated Serologic Non-responders Unknown status NCT01451801 Phase 4
38 Optimizing Treatment Programs for Chronic Kidney Disease-mineral and Bone Disorder and Malnutrition Unknown status NCT02005302 Phase 4 1,25(OH)2 Vitamin D3;Vitamin D2
39 Twinrix Alternative Schedule Study Unknown status NCT00216229 Phase 4
40 Trial Comparing the Efficacy, Tolerability and Safety Between Three Arms in Treatment of HCV in Egyptian Population Unknown status NCT01896609 Phase 4 Bon one in Arm 3;Xerovirinc in Arm 2;Ribavirin in Arm 1
41 Adjusting Antiretroviral Therapy Dosage Using Therapeutic Drug Monitoring Unknown status NCT00836212 Phase 4 Reducing dose of Lopinavir;Reducing dose of efavirenz
42 Immunogenicity of 1 or 2 Doses of bOPV in Chilean Infants Primed With IPV Vaccine Unknown status NCT01841671 Phase 4
43 Efficacy Optimizing Research of Chronic Hepatitis B Patients With Inadequate Response to NUC Therapy Unknown status NCT01341743 Phase 4 Entecavir;Entecavir, Adefovir;Entecavir, Adefovir
44 Using Entecavir to Reduce Hepatitis in Highly Viremic HBV Patients During Anti-tuberculous Treatment Unknown status NCT01724723 Phase 4 entecavir (BARACLUDE®)
45 Everolimus + Very Low Tacrolimus vs Enteric-coated Mycophenolate Sodium + Low Tacrolimus in de Novo Renal Transplant Unknown status NCT02084446 Phase 4 Everolimus;Very Low Tacrolimus;Low Tacrolimus;Steroids;Thymoglobulin;Sodium Mycophenolate
46 A Trial To Study The Effect Of Lamivudine In Adult Patients Who Suffer From Chronic Hepatitis B Alone Unknown status NCT00354653 Phase 4 LAMIVUDINE
47 Protease Inhibitor Monotherapy Versus Ongoing Triple-therapy in the Long Term Management of HIV Infection (PIVOT) Unknown status NCT01230580 Phase 4 Protease Inhibitor;Standard-of-care Antiretroviral therapy
48 Safety and Immunogenicity of Zostavax Vaccine in Patients Undergoing Living Donor Kidney Transplantation Unknown status NCT00940940 Phase 4
49 Pegylated Interferon Alfa-2b Plus Ribavirin in Chronic Hepatitis B and Delta Unknown status NCT00117533 Phase 4 pegylated IFN alfa-2b plus ribavirin
50 The Effects of Oral Hypoglycemic Agents on Chronic Hepatitis C Patients Receiving Peg-Intron Plus Ribavirin Unknown status NCT01025765 Phase 4 Pioglitazone;Acarbose;Metformin

Search NIH Clinical Center for Viral Infectious Disease

Inferred drug relations via UMLS 73 / NDF-RT 51 :


Cochrane evidence based reviews: arbovirus infections

Genetic Tests for Viral Infectious Disease

Anatomical Context for Viral Infectious Disease

MalaCards organs/tissues related to Viral Infectious Disease:

41
Liver, Testes, T Cells, Kidney, B Cells, Bone, Lung

Publications for Viral Infectious Disease

Articles related to Viral Infectious Disease:

# Title Authors Year
1
[Role of programmed death-1 in viral infectious diseases]. ( 29335088 )
2018
2
Evolutionary analysis of the dynamics of viral infectious disease. ( 19564871 )
2009
3
Viral infectious disease and natural products with antiviral activity. ( 22504360 )
2007
4
IL12 in acute viral infectious disease. ( 8839166 )
1995